iPath Optimized Currency Carry ETN
ICITF
Other OTC- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- iPath Optimized Currency Carry ETN (ICITF) is an exchange-traded note (ETN) issued by Barclays Bank PLC that provides investors exposure to an optimized currency carry strategy based on the Barclays Optimized Currency Carry Index. The ETN tracks performance through currency forward agreements on high-yielding G10 currencies, including the U.S. dollar, euro, Japanese yen, Canadian dollar, and others, aiming to capture interest rate differentials between higher-yielding funding currencies and lower-yielding target currencies while minimizing volatility through dynamic rebalancing; it matures on January 28, 2038, with investors receiving a cash payment based on the index performance less fees. Traded over-the-counter in the U.S. and listed internationally under related tickers like ICI, the product targets institutional and retail investors seeking currency market returns without direct forex exposure. Barclays Bank PLC, headquartered in London, United Kingdom, and founded in 1690, issues the iPath series of ETNs, including ICITF, as part of its broader capital markets and investment banking operations spanning North America, Europe, and Asia-Pacific. In recent years, Barclays has undertaken significant restructuring of its iPath ETN portfolio, including the redemption of 18 iPath ETNs in June 2024 via issuer call options and cash tender offers for 24 series announced in December 2023, though ICITF continues to trade actively with a recent price of $29.00 as of December 2025; no specific new product launches or partnerships directly tied to ICITF have been announced in the last 1-2 years.